The Research & Development team at hC Bioscience, Inc pioneers innovative approaches in protein editing using engineered tRNA technologies. This multidisciplinary team conducts cutting-edge research to develop new methodologies for direct proteome modification, advancing beyond traditional genome editing. Their collective efforts focus on discovering, formulating, and translating novel therapeutics to address unmet medical needs.
Alan Leggett
Associate Scientist, Research ...
Chris Katanski
Director, Platform Discovery
Lingyue Yan
Scientist I, Drug Development
Lingyue Yan
Formulation Scientist
Monika Tasak
Scientist I, tRNA biology
Philip McGilvray
Associate Director, Discovery ...
Sagi Ravid
Research Associate, Drug Devel...
Seyed Alireza Zamani...
Senior Computational Biologist
Seyed Alireza Zammi ...
Senior Computational Biologist
Trinayan Kashyap
Executive Director, Research &...
View all